Literature DB >> 1464753

Efflux of lipid from fibroblasts to apolipoproteins: dependence on elevated levels of cellular unesterified cholesterol.

J K Bielicki1, W J Johnson, R B Weinberg, J M Glick, G H Rothblat.   

Abstract

Earlier work from this laboratory showed that enrichment of cells with free cholesterol enhanced the efflux of phospholipid to lipoprotein acceptors, suggesting that cellular phospholipid may contribute to high density lipoprotein (HDL) structure and the removal of sterol from cells. To test this hypothesis, we examined the efflux of [3H]cholesterol (FC) and [32P]phospholipid (PL) from control and cholesterol-enriched fibroblasts to delipidated apolipoproteins. The percentages of [3H]cholesterol and [32P]phospholipid released from control cells to human apolipoprotein A-I were 2.2 +/- 0.5%/24 h and 0.8 +/- 0.1%/24 h, respectively. When the cellular cholesterol content was doubled, efflux of both lipids increased substantially ([3H]FC efflux = 14.6 +/- 3.6%/24 h and [32P]PL efflux = 4.1 +/- 0.3%/24 h). Phosphatidylcholine accounted for 70% of the radiolabeled phospholipid released from cholesterol-enriched cells. The cholesterol to phospholipid molar ratio of the lipid released from cholesterol-enriched cells was approximately 1. This ratio remained constant throughout an incubation time of 3 to 48 h, suggesting that there was a coordinate release of both lipids. The concentrations of apoA-I, A-II, A-IV, E, and Cs that promoted half-maximal efflux of phospholipid from cholesterol-enriched fibroblasts were 53, 30, 68, 137, and 594 nM, respectively. With apoA-I and A-IV, these values for half-maximal efflux of phospholipid were identical to the concentrations that resulted in half-maximal efflux of cholesterol. Agarose gel electrophoresis of medium containing apoA-I that had been incubated with cholesterol-enriched fibroblasts revealed a particle with alpha to pre-beta mobility. We conclude that the cholesterol content of cellular membranes is an important determinant in the ability of apolipoproteins to promote lipid removal from cells. We speculate that apolipoproteins access cholesterol-phosphatidylcholine domains within the plasma membrane of cholesterol-enriched cells, whereupon HDL is generated in the extracellular compartment. The release of cellular lipid to apolipoproteins may serve as a protective mechanism against the potentially damaging effects of excess membrane cholesterol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464753

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.

Authors:  M A Clay; D A Cehic; D H Pyle; K A Rye; P J Barter
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery disease.

Authors:  J Iwanejko; M Kwaśniak; I Wybrańska; J Hartwich; I Guevara; A Zdzienicka; O Kruszelnicka-Kwiatkowska; W Piwowarska; B Miszczuk-Jamska; A Dembińska-Kieć
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 3.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

4.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.

Authors:  A J Mendez; G M Anantharamaiah; J P Segrest; J F Oram
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  Detergent-mediated phospholipidation of plasma lipoproteins increases HDL cholesterophilicity and cholesterol efflux via SR-BI.

Authors:  Henry J Pownall
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

6.  Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

Authors:  V Atger; M de la Llera Moya; M Bamberger; O Francone; P Cosgrove; A Tall; A Walsh; N Moatti; G Rothblat
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 7.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

Review 8.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12

9.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture.

Authors:  Hirohisa Minagawa; Jiang-Sheng Gong; Cha-Gyun Jung; Atsushi Watanabe; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito; Makoto Michikawa
Journal:  J Neurosci Res       Date:  2009-08-15       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.